Big Pharma Exploits and Monetizes ‘Trans Identity’

Updated: Oct 15, 2021

Guest Post By Ben Bartee - July 15, 2021 orginally published in The Daily Bell

As Aldous Huxley laid out in excruciating detail in his seminal novel Brave New World, the totalitarian state of tomorrow will prop itself up not by brute force of the type seen in Orwell’s 1984, but rather via social conditioning and a pharmacological social control tool called medicalization:

“Medicalization can be defined as the process by which some aspects of human life come to be considered as medical problems, whereas before they were not considered pathological.”

Toxic masculinity, white fragility, five distinct classes of anxiety disorders, 7 classes of depression, “gender dysphoria” even in children as young as 2 years old – these are the products of medicalization.

In a remarkable letter penned to Orwell following the publication of 1984, Huxley further explains this theoretical divergence from Orwell in terms of how future rulers will exercise social control:

Within the next generation I believe that the world’s rulers will discover that… the lust for power can be just as completely satisfied by suggesting people into loving their servitude as by flogging and kicking them into obedience.”

-Aldous Huxley, 1949

How the hands on the clock have come around. In this pursuit, social control and the profit motive converge:

“The pharmaceutical industry is very interested in developing mood brighteners or happiness pills to meet increasing demands…. Medicalization is rooted in the field of mental disorders. For instance, individuals lacking personal resources to face certain life events (i.e. marital discord) are displacing the ‘usual’ psychiatric patients (i.e. those with schizophrenia).”

Here is how the process works in the context of “gender dysphoria” – a diagnosis, incidentally, which did not exist in clinical literature until 2013:

  • Young person feels insecure and unsure of their identity as they emerge from the cocoon of childhood into adulthood

  • Young person visits a psychiatrist and becomes a patient

  • Psychiatrist makes a “gender dysphoria” diagnosis according to the industry standard DMS-V. Young person now has a diagnosed psychiatric disorder which did not exist 8 years ago

  • Psychiatrist prescribes medication, the first and most common route of “treatment” (when all you have is a hammer, everything looks like a nail)

  • Young patient pays for and receives gender transition “therapy” with no red tape attached. The standard stages of “treatment” for gender dysphoria go like this:

  • Stage 1, puberty suppression

  • Stage 2, gender-affirming hormones

  • Stage 3, gender-affirming surgery

  • Doctors get paid.

  • The pharmaceutical corporations that produce the irreversible puberty blockers and hormones used in “therapy” get paid

  • Politicians who set the laws pertaining to transition “therapy” get their campaigns funded to the tune of billions of dollars in “donations” (read: investments) from said multinational pharmaceutical corporations

  • The government regulatory authorities – for example, Health and Human Services – theoretically responsible for policing said pharmaceutical manufacturers leave office and take up multi-million-dollar lobbying gigs at the companies they were previously tasked with regulating. This phenomenon is known as the public-to-private sector “revolving door“

All across the West – North America, Western Europe, Oceania – referrals for teenagers to receive hormone therapy have skyrocketed exponentially in the past 10 years.